Skip to content

Clinical trials

Phase 2 Lymphoma, Follicular trials in Austria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Follicular Phase: Phase 2 Country / region: Austria Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20152
20181
20192
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Terminated2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals2
Celgene1
Insel Gruppe AG, University Hospital Bern1
MEI Pharma, Inc.1
Swiss Cancer Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Follicular6
Lymphoma, Non-Hodgkin3
Lymphoma, B-Cell2
Lymphoma, B-Cell, Marginal Zone2
Lymphoma, Large B-Cell, Diffuse2
Recurrence2
Burkitt Lymphoma1
Dendritic Cell Sarcoma, Interdigitating1
Lymphoma, Mantle-Cell1

Trials

Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.